Moreover, these data were confirmed in samples from COVID-19-positive individuals displaying marked increases in CXCL9, CXCL10 and CXCL11 transcripts, and an upregulation of components of the AKT signaling pathway was observed via pathway analysis performed on transcriptomic data from these patients [41]. The gene discussed is CXCL9; the disease is COVID-19.